Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Small Cap Fund median (37 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 23 Dec 2020 – 20 Aug 2026, limited by UTI Small Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | UTI Small Cap Fund | Nifty Smallcap 250 |
|---|---|---|
| 23 Dec 2020 | ₹100.00 | ₹100.00 |
| 13 Jun 2021 | ₹130.23 | ₹142.86 |
| 02 Dec 2021 | ₹154.95 | ₹160.93 |
| 24 May 2022 | ₹143.13 | ₹144.32 |
| 12 Nov 2022 | ₹162.60 | ₹159.66 |
| 03 May 2023 | ₹162.33 | ₹160.93 |
| 22 Oct 2023 | ₹202.32 | ₹210.82 |
| 11 Apr 2024 | ₹226.09 | ₹261.56 |
| 30 Sep 2024 | ₹286.13 | ₹313.01 |
| 22 Mar 2025 | ₹248.72 | ₹259.14 |
| 10 Sep 2025 | ₹281.60 | ₹290.60 |
| 01 Mar 2026 | ₹262.04 | ₹270.00 |
| 20 Aug 2026 | ₹303.73 | ₹311.79 |
| Metric | UTI · Direct NAV ₹30.36 Very High risk ★★★☆☆ | Category median Small Cap Fund · 37 funds |
|---|---|---|
| +7.95% | +12.86% | |
| +17.01% | +18.08% | |
| +17.56% | +18.44% | |
| — | +17.52% | |
| +21.70% | +19.96% | |
| +16.10% | — | |
| +21.45% | +21.45% | |
| +18.54% | +21.03% | |
| — | +19.53% | |
| Risk | ||
| 16.79% | 17.14% | |
| 0.63 | 0.69 | |
| 0.85 | 0.93 | |
| -22.34% | -32.37% | |
| Nifty Smallcap 250 | — | |
| +0.82% | +2.27% | |
| 0.87 | 0.86 | |
| 88.8% | 88.4% | |
| 82.4% | 77.8% | |
| 0.87% | 0.92% | |
| ₹4,890Cr | ₹4,512Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 4% | 27% | |
| Nitin Jain | — | |
| 23 Dec 2020 | — | |
| 108 | — | |
| 20.3% | — | |
| 3.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.